Pharmaceutical Technology12 天
Vilastobart by Xilio Therapeutics for Leiomyosarcoma: Likelihood of Approval
small-cell lung cancer, metastatic castration-resistant prostate cancer, metastatic colorectal cancer, merkel cell carcinoma, cervical cancer, esophageal cancer, prostate cancer, gastric cancer, ...
Pharmaceutical Technology12 天
OMTX-705 by Oncomatryx Biopharma for Leiomyosarcoma: Likelihood of Approval
OMTX-705 is under clinical development by Oncomatryx Biopharma and currently in Phase I for Leiomyosarcoma. According to GlobalData, Phase I drugs for Leiomyosarcoma have a 92% phase transition ...
ascopubs.org1 个月
Next-Generation Sequencing–Guided Treatment of BRCA2-Mutant Metastatic Uterine ...
Clinical and Radiographic Benefit of a Patient With Metastatic Non-Small Cell Lung Cancer Harboring an EGFR::ERBB4 Fusion Through Use of EGFR Tyrosine Kinase Inhibitors In this report, we present a ...
The Argus on MSN4 天
Crawley driver walks 100km for Sarcoma UK in wife's memory
Crawley’s Donald Bradley will walk 100km along the Jurassic Coast in May 2025 to honour his late wife Jacky and raise funds for Sarcoma ...